Literature DB >> 15583807

Anti-carcinogenic and anti-metastatic properties of indole-3-carbinol in prostate cancer.

V P S Garikapaty1, B T Ashok, Y G Chen, A Mittelman, M Iatropoulos, R K Tiwari.   

Abstract

Indole-3-carbinol (I3C), a compound present as glucobracissin in cruciferous vegetables has anticancer activities which is in line with some of the epidemiological evidence that suggests a beneficial effect of consumption of cruciferous vegetables on cancer incidence and progression. The precise target of indole-3-carbinol has not been determined. We examined the effect of I3C on prostate cancer in a well-defined R3327 model using Copenhagen rats and the transplantable cell line, MAT-LyLu. This cell line derived from a tumor in Copenhagen rats is androgen independent and metastasizes to the lung and lymph nodes. Tumors were induced in Copenhagen rats by injecting MAT-LyLu subcutaneously and the animals treated with I3C that was administered either intraperitoneally or intravenously, in order to achieve maximal systemic exposure. This was a departure from the traditional chemopreventive route of indole-3-carbinol where the compound was incorporated in the diet. Our results indicate that I3C inhibited the incidence, growth and metastases of MAT-LyLu cells and both i.p. and i.v. injections of I3C were equally effective. Statistical analysis (Kaplan-Meier curves) clearly indicates a tumor-free and overall survival benefit as a result of treatment with I3C. These studies show for the first time that I3C in an injectible form has anti-prostate cancer activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15583807

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  7 in total

1.  Diet-related inflammation and risk of prostate cancer in the California Men's Health Study.

Authors:  Daria M McMahon; James B Burch; James R Hébert; James W Hardin; Jiajia Zhang; Michael D Wirth; Shawn D Youngstedt; Nitin Shivappa; Steven J Jacobsen; Bette Caan; Stephen K Van Den Eeden
Journal:  Ann Epidemiol       Date:  2018-11-02       Impact factor: 3.797

2.  3,3'-diindolylmethane modulates estrogen metabolism in patients with thyroid proliferative disease: a pilot study.

Authors:  Shilpi Rajoria; Robert Suriano; Perminder Singh Parmar; Yushan Lisa Wilson; Uchechukwu Megwalu; Augustine Moscatello; H Leon Bradlow; Daniel W Sepkovic; Jan Geliebter; Stimson P Schantz; Raj K Tiwari
Journal:  Thyroid       Date:  2011-01-22       Impact factor: 6.568

3.  Pharmacokinetic and Pharmacodynamic Properties of Indole-3-carbinol in Experimental Focal Ischemic Injury.

Authors:  Kakarla Ramakrishna; Shreyans K Jain; Sairam Krishnamurthy
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2022-04-28       Impact factor: 2.441

4.  Indole-3-carbinol prevents PTEN loss in cervical cancer in vivo.

Authors:  Mei Qi; Ann E Anderson; Da-Zhi Chen; Shishinn Sun; Karen J Auborn
Journal:  Mol Med       Date:  2005 Jan-Dec       Impact factor: 6.354

Review 5.  Improving the Health-Benefits of Kales (Brassica oleracea L. var. acephala DC) through the Application of Controlled Abiotic Stresses: A Review.

Authors:  Erika Ortega-Hernández; Marilena Antunes-Ricardo; Daniel A Jacobo-Velázquez
Journal:  Plants (Basel)       Date:  2021-11-29

Review 6.  Medical treatment of cervical intraepithelial neoplasia II, III: an update review.

Authors:  Chumnan Kietpeerakool; Jatupol Srisomboon
Journal:  Int J Clin Oncol       Date:  2009-02-20       Impact factor: 3.850

Review 7.  Anticancer Efficacy of Polyphenols and Their Combinations.

Authors:  Aleksandra Niedzwiecki; Mohd Waheed Roomi; Tatiana Kalinovsky; Matthias Rath
Journal:  Nutrients       Date:  2016-09-09       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.